# AlphaFold The [[Google DeepMind]] deep-learning system that predicts the three-dimensional structure of a protein from its amino-acid sequence — the achievement that earned [[Demis Hassabis]] and [[John Jumper]] half of the **2024 Nobel Prize in Chemistry** (the other half went to David Baker for computational protein design). **AlphaFold2** (2021) solved a roughly 50-year-old grand challenge in biology. DeepMind released its predicted structures in a public database that, by 2026, had been used by more than two million researchers across ~190 countries — accelerating work on malaria vaccines, cancer therapeutics, enzyme engineering, and drug-resistant bacteria. ## Why it matters for the KB AlphaFold is the canonical proof that frontier AI labs can produce transformative *scientific* output, not just chatbots — the template both [[Google DeepMind]] (via Isomorphic Labs) and [[Anthropic]] now invoke as they compete to apply deep learning to drug discovery and the life sciences. When [[John Jumper]] announced on June 19–20, 2026 that he was leaving DeepMind after nearly nine years for [[Anthropic]] — "GDM is a special place," he wrote, thanking Hassabis for letting him lead AlphaFold "just six months after finishing my PhD" — the move was read as a signal that Anthropic intends to compete in AI-for-science, not only in large language models. The vault's interest is the pattern: the scientific prestige of AlphaFold is the argument the labs make to governments for the [[AI Action Plan]]'s deregulation — cure cancer, or lose the race — and the researcher who earned that prestige now works for the lab that positions itself as the safety-minded one. See [[Dual-Use AI]] for the other half of the argument. ## See Also - [[John Jumper]] - [[Demis Hassabis]] - [[Google DeepMind]] - [[Anthropic]] - [[Dual-Use AI]]